Cai R

No ORCID on file · 21 papers in corpus · active 2017-2026

Study types

  • other 2

Condition tags

  • endometriosis 2
  • infertility 1
  • die_deep_infiltrating 1
other 2026
Clinical case reports ·doi:10.1002/ccr3.72676

This case report demonstrates the enhanced visualization capabilities of FAPI in visualizing deep infiltrating endometriosis (DIE) lesions compared to ultrasonography and MRI, suggesting its potential as a powerful diagnostic tool in the fu…

other 2022
Scientific reports ·doi:10.1038/s41598-022-08707-x

Infants conceived with in vitro fertilization (IVF) are exposed to underlying infertility and the IVF process. High risks of adverse birth outcomes (ABOs) were observed among these infants, including preterm birth, low birth weight, macroso…

2022
PLOS global public health ·doi:10.1371/journal.pgph.0000110

Menstrual hygiene management is an important determinant for girls' educational outcomes. We develop a method of cross-sectional analysis that quantifies the relative importance of four distinct mechanisms: material, biological, social and …

2022
Journal of clinical medicine ·doi:10.3390/jcm11123386

Ectopic pregnancy (EP) is increasingly found in women treated with in vitro fertilization and embryo transfer (IVF−ET). With the development of the freeze-all policy in reproductive medicine, it is controversial whether frozen embryo transf…

2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.965863

PurposeThe purpose of this study is to assess the safety of progestin-primed ovarian stimulation (PPOS) protocol regarding the neonatal outcomes and congenital malformations in babies born after in vitro fertilization (IVF) and frozen embry…

2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.677689

ObjectiveTo evaluate the clinical effect of mild stimulation with letrozole on pregnancy outcomes in ovulatory women undergoing frozen embryo transfer (FET) compared to natural cycle.DesignRetrospective observational study.SettingTertiary c…

2021
Frontiers in physiology ·doi:10.3389/fphys.2021.744968

BackgroundMany studies have demonstrated the positive clinical value of progestin-primed ovarian stimulation (PPOS) in patients with polycystic ovary syndrome (PCOS) who underwent assisted reproductive technology. However, the underlying fa…

2020
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-020-00597-w

BackgroundDecreased endometrial thickness (EMT) has been suggested to be associated with reduced birthweight of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) newborns. Considering the differences in ovarian stimulation …

2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.546232

ObjectiveTo evaluate whether endometrial thickness (EMT) change in response to progesterone has an effect on pregnancy outcomes in frozen-thawed embryo transfer (FET) cycles.DesignRetrospective observational study.SettingTertiary-care acade…

2020
Annals of translational medicine ·doi:10.21037/atm-20-1459

BackgroundPeak endometrial thickness (EMT), measured on the end of follicular phase or early luteal phase, is the most widely used marker for endometrial receptivity during infertility treatment. However, the clinical significance of follic…

2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00325

Background: The ability of anti-Müllerian hormone (AMH) to predict ovarian response has been studied extensively in gonadotropin-releasing hormone agonist and antagonist treatments, but no information is available regarding its value in pro…

2019
Frontiers in medicine ·doi:10.3389/fmed.2019.00316

The freeze-all strategy has been increasingly employed in the context of in vitro fertilization (IVF) cycles globally, but the relative advantages of this approach are not entirely understood. Herein we sought to assess how maternal age aff…

2019
Drug design, development and therapy ·doi:10.2147/dddt.s210228

PurposeDydrogesterone (DYG) has been demonstrated to be an alternative progestin in the progestin-primed ovarian stimulation (PPOS) protocol with comparable oocyte retrieval and pregnancy outcomes. However, its safety regarding neonatal out…

2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00694

Background: To investigate the optimal ovulation trigger-oocyte pickup (OPU) interval of a progestin-primed ovarian stimulation (PPOS) protocol. Method: Patients with normal ovarian reserve in their first PPOS OPU cycle were enrolled in thi…

2019
Drug design, development and therapy ·doi:10.2147/dddt.s212235

ObjectiveFrozen-thawed embryo transfer enables surplus embryos derived from IVF or IVF-ICSI treatment to be stored and transferred in subsequent cycles into a more "physiologic environment". This study aimed to investigate the clinical effe…

2019
Drug design, development and therapy ·doi:10.2147/dddt.s230129

PurposeDydrogesterone (DYG) is an alternative progestin in progestin-primed ovarian stimulation (PPOS) protocol with weaker pituitary suppression than medroxyprogesterone acetate (MPA) in normal ovulatory women. However, the endocrinologica…

2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00796

Objective: Progestin was recently used as an alternative of gonadotropin-releasing hormone (GnRH) analog for preventing premature luteinizing hormone (LH) surge with the aid of vitrification techniques, however, limited data were available …

2019
Annals of translational medicine ·doi:10.21037/atm.2019.11.74

BackgroundNon-elective freeze-all policy has been increasingly utilized in assisted reproductive treatment, but the optimal timing of frozen-thawed embryo transfer (FET) after controlled ovarian stimulation (COS) remains to be investigated.…

2018
Journal of ovarian research ·doi:10.1186/s13048-018-0469-x

BackgroundPremature ovulation occurs at a high rate in natural-cycle in vitro fertilization (IVF), and cycle cancellation further hampers the overall efficiency of the procedure. While lower levels of estradiol (E2) are observed in preovula…

2018
Trials ·doi:10.1186/s13063-018-2850-x

BackgroundProgress in vitrification techniques has allowed reproductive physicians to consider new strategies for using progestin as an alternative to a GnRH analogue to improve in vitro fertilisation (IVF). However, the role of progestin i…

2017
Oncotarget ·doi:10.18632/oncotarget.20508

Progestin-primed ovarian stimulation (PPOS) protocol has recently been demonstrated to be an novel regimen for preventing premature LH surges during controlled ovarian hyperstimulation (COH) in combination with frozen-thawed embryo transfer…